These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8342796)

  • 1. Should we use muscle biopsy to diagnose malignant hyperthermia susceptibility?
    Larach MG
    Anesthesiology; 1993 Jul; 79(1):1-4. PubMed ID: 8342796
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis.
    Hackl W; Winkler M; Mauritz W; Sporn P; Steinbereithner K
    Br J Anaesth; 1991 Jan; 66(1):138-40. PubMed ID: 1997050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle biopsy testing for malignant hyperthermia.
    Allen G; Rosenberg H
    Plast Reconstr Surg; 1989 Aug; 84(2):373-4. PubMed ID: 2748763
    [No Abstract]   [Full Text] [Related]  

  • 4. Should malignant hyperthermia-susceptible patients undergo muscle biopsy?
    Hinkle AJ
    Anesthesiology; 1994 Mar; 80(3):708-9. PubMed ID: 8141476
    [No Abstract]   [Full Text] [Related]  

  • 5. False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia.
    Isaacs H; Badenhorst M
    Anesthesiology; 1993 Jul; 79(1):5-9. PubMed ID: 8342829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle biopsy proven malignant hyperpyrexia and minimal symptoms under inhalational anaesthesia.
    Pemberton DM
    Anaesth Intensive Care; 1991 Feb; 19(1):133-4. PubMed ID: 2012285
    [No Abstract]   [Full Text] [Related]  

  • 7. Propofol in malignant hyperthermia.
    Harrison GG
    Lancet; 1991 Feb; 337(8739):503. PubMed ID: 1671514
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis and management of susceptibility to malignant hyperthermia in pregnancy.
    Sorosky JI; Ingardia CJ; Botti JJ
    Am J Perinatol; 1989 Jan; 6(1):46-8. PubMed ID: 2910318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospective evaluation of a nuclear magnetic resonance score in the screening of malignant hyperthermia susceptibility. Initial results].
    Payen JF; Bosson JL; Stieglitz P
    Ann Fr Anesth Reanim; 1996; 15(1):47-48. PubMed ID: 8729310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical concentrations of verapamil affect the in vitro diagnosis of susceptibility to malignant hyperpyrexia.
    Adnet PJ; Krivosic-Horber RM; Adamantidis MM; Haudecoeur G; Reyfort GH; Dupuis BA
    Br J Anaesth; 1990 Jan; 64(1):64-6. PubMed ID: 2302378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal reaction.
    Little S
    Nurs Times; 1990 Feb 28-Mar 6; 86(9):20-1. PubMed ID: 2315160
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical presentation of suspected malignant hyperthermia during anaesthesia in 402 probands.
    Ellis FR; Halsall PJ; Christian AS
    Anaesthesia; 1990 Oct; 45(10):838-41. PubMed ID: 2240497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant hyperthermia and central core disease: analysis of two families with heterogeneous clinical expression.
    Romero NB; Nivoche Y; Lunardi J; Bruneau B; Cheval MA; Hillaire D; Fardeau M
    Neuromuscul Disord; 1993; 3(5-6):547-51. PubMed ID: 8186709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of the caffeine halothane muscle contracture test. North American Malignant Hyperthermia Group.
    Larach MG
    Anesth Analg; 1989 Oct; 69(4):511-5. PubMed ID: 2675676
    [No Abstract]   [Full Text] [Related]  

  • 15. General anesthesia with dexmedetomidine in a malignant hyperthermia-susceptible woman.
    Unger RJ
    Acta Anaesthesiol Scand; 2006 Nov; 50(10):1312-3. PubMed ID: 17067340
    [No Abstract]   [Full Text] [Related]  

  • 16. A medical student with malignant hyperthermia susceptibility.
    Underwood N; Austin JD
    Anaesth Intensive Care; 2012 Mar; 40(2):356. PubMed ID: 22417041
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenal cortical reserve in patients undergoing muscle biopsy for malignant hyperthermia screening.
    Fairbrass MJ; Coe P; Ellis FR
    Br J Anaesth; 1989 Jan; 62(1):66-9. PubMed ID: 2917113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyopathy in malignant hyperthermia.
    Rivera VM; Patten BM
    J Clin Psychiatry; 1978 Jan; 39(1):67-71. PubMed ID: 580262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and morphological findings in a case of malignant hyperthermia (author's transl)].
    Faber P; Gullotta F; Koenen FW
    Dtsch Med Wochenschr; 1975 Sep; 100(39):1974-6. PubMed ID: 1157706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanesthetic investigation of malignant hyperthermia: microscopy.
    Harriman DG
    Int Anesthesiol Clin; 1979; 17(4):97-117. PubMed ID: 521181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.